Call Center Voice Agent
AI voice agent that handles initial patient triage calls before nurse handoff
Company profile
Company profile
Infermedica (operating as Disior Ltd) is a clinical AI company that provides medical-grade triage and symptom assessment solutions for healthcare organizations worldwide. Founded in 2012, the company has deployed its technology across 30+ countries, performing over 26 million health checkups. Their platform uses conversational AI to guide patients through symptom assessment via chat, voice, or call center interactions, helping them navigate to the appropriate level of care. The company's core offering includes three main products: Conversational Triage for digital front door applications, Voice Agent for call center support, and pre-visit intake tools that collect structured patient data before consultations. Their Medical Guidance Platform is certified as a Class IIb medical device under EU MDR and registered with the UK MHRA, ensuring clinical safety and regulatory compliance. Infermedica serves multiple healthcare sectors including public health systems, health plans and insurers, healthcare providers, telemedicine companies, and pharmaceutical companies. Their technology has been peer-reviewed in prestigious journals including the New England Journal of Medicine AI and Mayo Clinic Proceedings, with studies demonstrating improved care-acuity alignment, reduced ED visits, and cost-to-savings ratios of up to 1:10. The platform covers mental health assessment alongside physical symptoms, supports multiple languages, and integrates evidence-based patient education created by medical doctors.
Company description Disior Ltd official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Api Only · Cloud Saas deployment with recorded integration context.
Company milestones
MDR Class IIb certification achieved, deployment across 30+ countries, 26+ million health checkups performed
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI voice agent that handles initial patient triage calls before nurse handoff
Natural dialogue triage with medical-device-grade safety and auditability
Probabilistic modeling API for symptom analysis and triage recommendations
AI-driven patient intake that collects structured data before consultations
AI-powered virtual triage for accurate symptom assessment and care navigation
Extensive database of diseases, symptoms, and medical conditions for AI analysis
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Clinical anatomy (New York, N.Y.) · May 1, 2021
Reliability of orbital volume measurements based on computed tomography segmentation: Validation of different algorithms in orbital trauma patients.Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery · Jun 1, 2020
Automatic evaluation of the orbital shape after application of conventional and patient-specific implants: Correlation of initial trauma patterns and outcome.Journal of oral biology and craniofacial research · Jan 1, 2020
Clinical validation
No linked records are currently available.
Regulatory
K250023 · 510k · Sep 29, 2025
SMART Bun-Yo-Matic X-RayK240736 · 510k · Jul 2, 2024
SMART Bun-Yo-Matic CTK240642 · 510k · Jun 20, 2024
BonelogicK223757 · 510k · Dec 8, 2023
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Virtual triage deployments in national health systems
Healthdirect Australia implementation
Across millions of triage interviews
National evaluation of 1.55 million encounters
Mayo Clinic study
Connecting citizens with healthcare services through improved self-assessment tools
Improved self-assessment adoption and completion rates, positively impacted overall health system efficiency
Pre-visit patient intake automation to reduce consultation time and administrative burden
37.5% shorter average visit time - reduced from 20 minutes to 12.5 minutes
National digital front door implementation to improve symptom checker adoption and reduce pressure on emergency services
35% increase in completion rates and 30%+ jump in total users since December 2023
AI-powered virtual triage integrated into patient-facing tools to improve efficiency and reduce costs
Improved efficiency and reduced costs through virtual triage integration
Triage interviews to identify patients requiring urgent medical attention
Approximately 2 in every 1,000 triage interviews led to potentially life-saving care escalations
Virtual care adoption on a national scale to improve care-acuity alignment
Improved care-acuity alignment, reduced ED visits, and drove adoption of alternative care pathways across 1.55 million encounters
Platform optimization to increase operational efficiency
39% increase in operational efficiency
05 · Leadership
Leadership profiles and professional links from the current Company record.
06 · Company updates
Recent articles published on Disior Ltd's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.